Mary Holland

Former Global Business Development Strategist for the Molecular Diagnostics Division, MRI Global

Holland photo 3.12.13Ms. Holland brings years of experience in creating and expanding market segments in Clinical Molecular Diagnostics, with a focus on the development and marketing of core product lines for clinical reference laboratories and diagnostic product manufacturers.

Holland has served in multiple leadership roles, playing a key role in solidifying brand and product awareness as well as driving profits for multiple companies that went public or to a merger/acquisition by Fortune 500 companies.

Ms. Holland brings extensive experience in sales and marketing for clinical reference laboratories (CLIA) and diagnostic product manufacturers.  Ms. Holland has successfully developed core product lines, achieved new brand and product awareness with measured revenue results for companies across unique technology platforms.  Ms. Holland previously served as Vice President of Sales and Marketing with Madison, Wisconsin-based EraGen Biosciences, which was acquired by Luminex (NASDAQ: LMNX); prior to that she played an integral role in launching Third Wave Technologies (NASDAQ: HOLX). As an entrepreneur, she co-founded Oncogenetics Inc., a comprehensive cancer diagnostic reference laboratory, acquired by Genzyme Oncology Inc. (NASDAQ: GZMO).